ADVERTISEMENT
Videos
Real-World Treatment Patterns of Bruton Tyrosine Kinase Inhibitors Among Patients With Mantle Cell Lymphoma
06/14/2022
Bijal Shah, MD, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, discusses his study which assessed patient characteristics, treatment patterns and associated outcomes in real-world BTKi-treated patients with MCL.
This study was presented at the 2022 ASCO Annual Meeting.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Current Issue
June 2024
Volume 10
Issue 3
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Subscribe
Journal of Clinical Pathways Newsletter
Advertisement
Advertisement
Advertisement
Recent Stories
Advertisement